Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New skin patch for MS & colitis drug tested

NCT ID NCT06528665

Summary

This study tested a new skin patch designed to deliver the drug ozanimod, which is used for multiple sclerosis and ulcerative colitis. Researchers compared how the body absorbs the drug from three different patch formulas versus the standard oral capsule. The goal was to see if the patch could be a safe and effective alternative way to deliver the medication.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Hospital Ampang

    Ampang, Selangor, 68000, Malaysia

Conditions

Explore the condition pages connected to this study.